卡维迪洛尔在SCN8A衍生的的小鼠模型中增加了抗发作能力

相关实验视频

Updated: May 11, 2026

Simultaneous Video-EEG-ECG Monitoring to Identify Neurocardiac Dysfunction in Mouse Models of Epilepsy
11:54

Simultaneous Video-EEG-ECG Monitoring to Identify Neurocardiac Dysfunction in Mouse Models of Epilepsy

Published on: January 29, 2018

25.4K

Jennifer C Wong1, Andrew Escayg1

  • 1Department of Human Genetics, Emory University, Atlanta, GA, United States.

Frontiers in pharmacology
|June 19, 2024
PubMed
概括

研究人员选了SCN8A相关的化合物. 卡维迪醇显示出前景,显著增加突变小鼠的抗发作能力,表明其作为SCN8A突变患者治疗剂的潜力.

关键词:
这就是SCN8A.阿米特里普提林氨基的使用.卡尔维迪醇是一种是一种.发作的易感性 发作的易感性

更多相关视频

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy06:58

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy

Published on: July 12, 2021

4.8K
Preparation and Implantation of Electrodes for Electrically Kindling VGAT-Cre Mice to Generate a Model for Temporal Lobe Epilepsy09:29

Preparation and Implantation of Electrodes for Electrically Kindling VGAT-Cre Mice to Generate a Model for Temporal Lobe Epilepsy

Published on: August 17, 2021

2.4K

相关概念视频

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...